Track topics on Twitter Track topics that are important to you
418 Cambridge Science Park
Phone: 44 (0)1223 477910
Fax: 44 (0)1223 477911
Paradigm Spine tapped Francis Magee, who has 25 years of orthopedic and spine device industry experience, to serve as its chi -More-
Paradigm Spine's Coflex interlaminar stabilization disposable instrument kit has been granted premarket approval by the FDA. -More-
Paradigm Spine has secured pre-market supplemental approval (PMA) from the US Food and Drug Administration (FDA) for its coflex Interlaminar Stabilization disposable instrument kit.
Paradigm Asset Management Co. LLC lessened its position in shares of Bristol-Myers Squibb by 6.1% in the first quarter, according to the company in its most recent disclosure with the Securities &...
The prevailing paradigm for treating patients with osteoporosis is to begin with a generic oral bisphosphonate, such as alendronate, unless there is a contraindication for doing so. Patients are usual...
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Alec Mian, CEO at Genmedica Therapeutics about their novel approach to loo...
PE Biosystems Group (Foster City, CA) and Paradigm Genetics Inc. (Research Triangle Park, NC) have signed a five-year collaborative research agreement to develop bioinformatics software for functional...
Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.
ALDEX GS™ Tablets
ALDEX GS DMTablets
Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...
Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...
The emerging field of regenerative rehabilitation integrates biological and bioengineering advances in regenerative medicine with rehabilitative sciences. Here we highlight recent stem cell-based exam...
Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educationa...
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
The purpose of this study is to determine whether Type 1 Diabetic subjects using the Paradigm 722 System, which is a glucose sensor-augmented insulin pump, can improve glycemic control whe...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment ...
Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome. The race to define biological function of the thousands of uncharacterised ...
The Paradigm Award was created to honor hospitals that have gone above and beyond in their efforts to foster efficient labor practices without resorting to workforce reductions or dramatic top-down ma...
Founded in 1996, Paradigm Medical Industries, Inc. develops, manufactures, and markets diagnostic and surgical equipment for the ophthalmic market. The company specialized in powerful, easy-to-use, v...
Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine. Semmaâs new class of regenerative medicine therapies couples its breakthrough stem cel...
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pi...
We have published hundreds of Paradigm Therapeutics Ltd news stories on BioPortfolio along with dozens of Paradigm Therapeutics Ltd Clinical Trials and PubMed Articles about Paradigm Therapeutics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paradigm Therapeutics Ltd Companies in our database. You can also find out about relevant Paradigm Therapeutics Ltd Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...